Fol. Biol. 2010, 56, 206-210

https://doi.org/10.14712/fb2010056050206

Th1/Th2 Cytokine Gene Polymorphisms in Patients With Uterine Fibroid

O. Sosna1, Libor Kolesár2, A. Slavčev2, J. Skibová3, T. Fait1, M. Mara1, I. Stříž4, D. Kužel1

1Charles University in Prague, First Faculty of Medicine and General University Hospital, Department of Gynaecology and Obstetrics, Prague, Czech Republic
2Institute for Clinical and Experimental Medicine, Department of Immunogenetics, Prague, Czech Republic
3Institute for Clinical and Experimental Medicine, Department of Medical Statistics, Prague, Czech Republic
4Institute for Clinical and Experimental Medicine, Department of Clinical and Transplant Immunology, Prague, Czech Republic

Received April 2010
Accepted May 2010

Uterine fibroid or leiomyoma is a frequent non-malignant tumour with unknown aetiology and pathogenesis. The aim of our study was to look for possible genetic markers which could be used as prognostic tools for evaluation of an increased risk for development of uterine fibroid. A large spectrum of Th1/Th2 cytokine gene polymorphisms in 102 patients with uterine leiomyoma was compared with 145 healthy controls. An association between polymorphisms of the IL4 gene promotor at positions -590 C/T and -33 C/T, and the risk of leiomyoma was observed. The CC genotype of IL4 -590 and at position -33 was less frequent in the patient group than in the control group (P = 0.03). Besides IL-4, we observed different genotype distribution of the TNFA gene -308 A/G. The frequency of genotype AA was higher in the younger (≤ 35 years) patient group (P = 0.02). Our study thus suggests that certain cytokine gene polymorphisms, especially of the IL4 and TNFA genes, may be associated with increased risk for development of uterine fibroid. Further investigation would be needed to elucidate the mechanisms responsible for these associations.

Funding

This study was financially supported by the following grants: GA UK No. 38108 and IGA No. NS 9798-4.

References

27 live references